M2-TAM-derived XCL2 suppresses paclitaxel sensitivity in triple-negative breast cancer by transcriptionally activating NEK2
- DOI
- 10.4149/neo_2026_260507n143
- Published
- 2026-10-15
- Container
- Neoplasma
- Publisher
- AEPress, s.r.o.
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.4149/neo_2026_260507n143,
title = {M2-TAM-derived XCL2 suppresses paclitaxel sensitivity in triple-negative breast cancer by transcriptionally activating NEK2},
author = {Youyuan Deng and Ye He and Hongjun Zhao and Lifen Ye and Jingyong Li and Zhiya Hu and Huaixiao Zhang and Chao Zhang and Qishuo Rao and Yurong Cai and Yiping Xu and Jianguo Wang},
year = {2026},
journal = {Neoplasma},
doi = {10.4149/neo_2026_260507n143},
url = {https://doi.org/10.4149/neo_2026_260507n143}
}RIS
TY - JOUR TI - M2-TAM-derived XCL2 suppresses paclitaxel sensitivity in triple-negative breast cancer by transcriptionally activating NEK2 AU - Youyuan Deng AU - Ye He AU - Hongjun Zhao AU - Lifen Ye AU - Jingyong Li AU - Zhiya Hu AU - Huaixiao Zhang AU - Chao Zhang AU - Qishuo Rao AU - Yurong Cai AU - Yiping Xu AU - Jianguo Wang PY - 2026 JO - Neoplasma DO - 10.4149/neo_2026_260507n143 UR - https://doi.org/10.4149/neo_2026_260507n143 ER -
APA
Deng, Y., He, Y., Zhao, H., Ye, L., Li, J., Hu, Z., Zhang, H., Zhang, C., Rao, Q., Cai, Y., Xu, Y., & Wang, J. (2026). M2-TAM-derived XCL2 suppresses paclitaxel sensitivity in triple-negative breast cancer by transcriptionally activating NEK2. Neoplasma. https://doi.org/10.4149/neo_2026_260507n143
Source records
- crossref · retrieved 2026-11-04T13:31:25.291Z